Agmatine
Agmatine Sulfate
A versatile neuromodulator derived from arginine that supports mood, neuroprotection, pain management, and nitric oxide regulation.
Agmatine is a metabolite of the amino acid arginine, produced by removing the carboxylic acid group. It functions as a neurotransmitter and neuromodulator with diverse effects including NMDA receptor antagonism, imidazoline receptor agonism, and nitric oxide synthase modulation. It has shown promise for mood support, neuroprotection, pain management, and may help regulate tolerance to stimulants and opioids.
Mechanisms of Action
NMDA Antagonism
Blocks NMDA receptors
Imidazoline Receptor Agonist
Activates imidazoline receptors
Nitric Oxide Modulation
Regulates NO synthase
Recommended Dose
500-2500mg daily
Loading: Not required
Optimal Timing
- Empty stomach for mood/nootropic effects
- Pre-workout for pumps
- Before bed for neuroprotection
Can be taken without food
Best Form
Agmatine Sulfate
Agmatine sulfate is the standard supplemental form. Available as powder or capsules.
Duration
Minimum: 4 weeks
Optimal: 12 weeks
Cycling: 4-6 weeks on, 1-2 weeks off; or as needed for workout support
Note: Better absorbed on empty stomach. For workout purposes, take 30-60 minutes before training.
Personalized Dosage Calculator
Get a dosage recommendation tailored to your body weight, age, goals, and health profile.
Set up your health profile for personalized recommendations
Mood Support
Antidepressant-like effects
Pain Relief
May reduce neuropathic pain
Tolerance Prevention
May prevent tolerance to certain substances
Enhanced Pumps
Improved vascularity during exercise
Promising adjunct; consult with doctor before use
Who Should NOT Take This
- Known allergy or hypersensitivity to Agmatine or related compounds
Drug Interactions
May enhance hypotensive effects
May affect insulin sensitivity; monitor glucose
Possible Side Effects
Tip: Take with food if needed
Tip: Start with lower dose
Warnings
- Limited long-term human safety data
- May interact with blood pressure and diabetes medications
- Not well-studied in pregnancy
Top studies from 40+ peer-reviewed papers
Watanabe S et al. • Science advances (2025)
“Lubiprostone is a previously unknown and safe therapeutic option to mitigate renal decline in CKD.”
Key Findings:
- Lubiprostone did not alter uremic toxin levels but improved or preserved estimated glomerular filtration rate and its slope in the 16-microgram group.
- Mild-to-moderate gastrointestinal events occurred in the placebo and 16-microgram groups.
- Multiomics analysis revealed that lubiprostone modulated the gut microbial agmatine pathway and increased spermidine levels, thereby improving renal mitochondrial function.
- Lubiprostone is a previously unknown and safe therapeutic option to mitigate renal decline in CKD.
Manole OM et al. • Medical sciences (Basel, Switzerland) (2025)
“The effects exerted by AG depend on the dose and route of administration, as well as on the receptors involved and the pathophysiological pathway used.”
Key Findings:
- The effects exerted by AG depend on the dose and route of administration, as well as on the receptors involved and the pathophysiological pathway used.
- Published in Medical sciences (Basel, Switzerland) (2025)
- Further research warranted to confirm findings
Kouba BR et al. • Cells (2024)
“Further studies are necessary to explore the therapeutic benefits of these alternative therapies for MDD.”
Key Findings:
- Together, neuroinflammation and gut dysbiosis induce alterations in tryptophan metabolism, culminating in decreased serotonin synthesis, impairments in neuroplasticity-related mechanisms, and glutamate-mediated excitotoxicity.
- This review aims to highlight the inflammatory mechanisms (neuroinflammation, peripheral inflammation, and gut dysbiosis) involved in the pathophysiology of MDD and to explore novel anti-inflammatory therapeutic approaches for this psychiatric disturbance.
- Several lines of evidence have indicated that in addition to antidepressants, physical exercise, probiotics, and nutraceuticals (agmatine, ascorbic acid, and vitamin D) possess anti-inflammatory effects that may contribute to their antidepressant properties.
- Further studies are necessary to explore the therapeutic benefits of these alternative therapies for MDD.
Paley EL • Journal of Alzheimer's disease : JAD (2019)
“ADAS is attributable to potentially modifiable risk factors of AD associated diseases.”
Key Findings:
- Biogenic amines (histamine, tryptamine, tyramine, phenylethylamine, cadaverine, putrescine, agmatine, spermidine) that present in food and are produced by gut microbiota are significantly higher in C&A (e.g., histamine/histidine 95-fold) versus NNI (histamine/histidine 16-fold).
- The seizure-eliciting tryptamine induced cytoplasmic vacuolization and vesiculation with cell fragmentation.
- Present additions of ADAS-carriers at different ages including infants led to an ADAS-comprising human sample size of 2,830 from 27 studies from four continents (North America, Australia, Asia, Europe).
- Levels of food-derived monoamine oxidase inhibitors and anti-bacterial compounds, the potential modulators of ADAS-bacteria growth and biogenic amine production, were altered in C&A versus NNI.
Moretti M et al. • Frontiers in bioscience (Elite edition) (2014)
“Moreover, some molecular mechanisms underlying the neuroprotective effects of agmatine will be discussed.”
Key Findings:
- Agmatine, a cationic polyamine synthesized after decarboxylation of L-arginine by the enzyme arginine decarboxylase, is an endogenous neuromodulator that emerges as a potential agent to manage diverse central nervous system (CNS) disorders.
- The aim of this review is to summarize the knowledge about the effects of agmatine in CNS and point out its potential as new pharmacological treatment for diverse neurological and neurodegenerative diseases.
- Moreover, some molecular mechanisms underlying the neuroprotective effects of agmatine will be discussed.
Study Type Distribution
Goals This Supplement Supports
Related Goals
This information is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any supplement.